CLRB
Cellectar Biosciences Inc
NASDAQ: CLRB · HEALTHCARE · BIOTECHNOLOGY
$2.56
-0.02% today
Updated 2026-04-29
Market cap
$11.70M
P/E ratio
—
P/S ratio
348.47x
EPS (TTM)
$-8.35
Dividend yield
—
52W range
$2 – $21
Volume
0.0M
Cellectar Biosciences Inc (CLRB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-6.47M | $-13.47M | $-17.33M | $-10.62M | $-7.80M | $-5.97M | $-6.59M | $-9.15M | $-8.84M | $-8.21M | $-8.28M | $-11.02M | $-11.44M | $-11.69M | $-13.93M | $-22.57M | $-25.22M | $-32.38M | $-47.58M | $-23.12M |
| Capital expenditures | $10716.00 | $24366.00 | $49003.00 | $18000.00 | $3.00 | $118411.00 | $97691.00 | $147812.00 | $29569.00 | $58470.00 | $72251.00 | $346703.00 | $384993.00 | $24542.00 | $62353.00 | $141361.00 | $225971.00 | $864038.00 | $104199.00 | $5880.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $588043.00 | $503290.00 | $453327.00 | $864337.00 | $353340.00 | $907460.00 | $1.50M | $2.32M | $850350.00 | $447300.00 | $529159.00 | $758757.00 | $721209.00 | $866791.00 | $467541.00 | $1.12M | $1.45M | $2.41M | $4.27M | $2.26M |
| Free cash flow | $-6.48M | $-13.49M | $-17.38M | $-10.64M | $-7.80M | $-6.09M | $-6.68M | $-9.30M | $-8.87M | $-8.27M | $-8.35M | $-11.37M | $-11.83M | $-11.72M | $-14.00M | $-22.71M | $-25.45M | $-33.24M | $-47.69M | $-23.12M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | $261120.00 | $823620.00 | $740280.00 | $1.90M | $5.11M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.45M | $2.24M | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | $-2.26M | $7.00M | $-5.56M | $7.59M | $-1.44M | $3.25M | $-2.70M | $46.55M | — | — | — | — | — |